ArticleDiabetes, obesity & metabolism2025

Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy.

Anıl Cengiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.